Pacira BioSciences
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
EVNIN LUKE director
Common Stock 9,935 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 3,033 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 2,500 N/A N/A
Sale
EVNIN LUKE director
Common Stock 44,582 N/A N/A
Sale
EVNIN LUKE director
Common Stock 20,411 N/A N/A
Sale
EVNIN LUKE director
Common Stock 195,117 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 18,471 N/A N/A
Sale
EVNIN LUKE director
Common Stock 7,340 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 14,374 N/A N/A
Sale
EVNIN LUKE director
Common Stock 13,550 N/A N/A
Purchase
HASTINGS PAUL J director
Common Stock 853 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 401 N/A N/A
Sale
EVNIN LUKE director
Common Stock 6,303 N/A N/A
Sale
EVNIN LUKE director
Common Stock 108,115 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 15,646 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 6,400 N/A N/A
Sale
EVNIN LUKE director
Common Stock 2,575 N/A N/A
Sale
EVNIN LUKE director
Common Stock 13,416 N/A N/A
Option
PATOU GARY officer: Chief Medical Officer
Common Stock 10,000 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 34,294 N/A N/A
Sale
PATOU GARY officer: Chief Medical Officer
Common Stock 10,000 N/A N/A
Sale
EVNIN LUKE director
Common Stock 13,416 $15 $201,240
Option
PATOU GARY officer: Chief Medical Officer
Stock Option (Right to Buy) 10,000 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 600 N/A N/A
Sale
PATOU GARY officer: Chief Medical Officer
Common Stock 30,000 N/A N/A
Option
PATOU GARY officer: Chief Medical Officer
Common Stock 30,000 N/A N/A
Option
PATOU GARY officer: Chief Medical Officer
Stock Option (Right to Buy) 30,000 N/A N/A
Option
LONGENECKER JOHN P PHD director
Stock Option (right to buy) 2,000 N/A N/A
Option
SCIBETTA JAMES S officer: President
Employee Stock Option (right to buy) 10,000 N/A N/A
Sale
SCIBETTA JAMES S officer: President
Common Stock 10,000 N/A N/A
Option
SCIBETTA JAMES S officer: President
Common Stock 10,000 N/A N/A
Option
STACK DAVID M director, officer: CEO and Chai..
Employee Stock Option (right to buy) 15,000 N/A N/A
Sale
LONGENECKER JOHN P PHD director
Common Stock 2,000 N/A N/A
Option
STACK DAVID M director, officer: CEO and Chai..
Common Stock 15,000 N/A N/A
Sale
STACK DAVID M director, officer: CEO and Chai..
Common Stock 15,000 N/A N/A
Option
LONGENECKER JOHN P PHD director
Common Stock 2,000 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 165,541 N/A N/A
Sale
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD. 10 percent owner
Common Stock 165,541 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 113,928 N/A N/A
Sale
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD. 10 percent owner
Common Stock 113,928 N/A N/A
Sale
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD. 10 percent owner
Common Stock 11,431 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 11,431 N/A N/A
Sale
HBM BIOVENTURES CAYMAN LTD
Common Stock 9,100 N/A N/A
Sale
SANDERLING VENTURE PARTNERS VI LP 10 percent owner
Common Stock 84,589 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 9,100 N/A N/A
Sale
WICKI ANDREAS director
Common Stock 400,000 N/A N/A
Sale
HBM BIOVENTURES CAYMAN LTD
Common Stock 400,000 N/A N/A
Sale
EVNIN LUKE director
Common Stock 500,000 N/A N/A
Sale
SANDERLING VENTURE PARTNERS VI LP 10 percent owner
Common Stock 135,996 N/A N/A
Sale
RIKER LAUREN BULLARO officer: Vice President, Finance
Common Stock 10,000 N/A N/A

Showing 750 to 800 of 846 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.